Escient Pharmaceuticals is a biotech company specializing in the treatment of neurosensory-inflammatory disorders. Escient’s therapeutic programs apply state-of-the-art chemistries and biological understanding for its highly differentiated treatments using a novel class of cellular receptors called Mass-related G protein-coupled receptors (MRGPRS) that can detect and target a broad range of neuro-diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/28/2022 | Series C | $120MM | $xx.xx | $256.49MM | NEA, Abingworth, Forge Life Science Partners, Avego, PFM Health Sciences, The Eleven Fund, The Column Group, 5AM Ventures, Redmile Group, Cowen Healthcare Investments, Sanofi Ventures, Osage University Partners, Altitude Life Science Ventures | |
Price per Share
$xx.xx
Shares Outstanding
160,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
NEA, Abingworth, Forge Life Science Partners, Avego, PFM Health Sciences, The Eleven Fund, The Column Group, 5AM Ventures, Redmile Group, Cowen Healthcare Investments, Sanofi Ventures, Osage University Partners, Altitude Life Science Ventures
|
||||||
09/14/2020 | Series B | $82.96MM | $xx.xx | $178.2MM | Sanofi Ventures, Cowen Healthcare Investments, Redmile Group, Perceptive Advisors, The Column Group, 5AM Ventures, Osage University Partners | |
Price per Share
$xx.xx
Shares Outstanding
66,371,941
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sanofi Ventures, Cowen Healthcare Investments, Redmile Group, Perceptive Advisors, The Column Group, 5AM Ventures, Osage University Partners
|
||||||
05/09/2018 | Series A | $40.55MM | $xx.xx | $67.58MM | The Column Group, 5AM Ventures, Osage University Partners | |
Price per Share
$xx.xx
Shares Outstanding
40,546,205
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
The Column Group, 5AM Ventures, Osage University Partners
|